CRISPR-RELATED METHODS AND COMPOSITIONS TARGETING CD70 EXPRESSION
Application
US20260083861A1
Kind: A1
Mar 26, 2026
Assignee
Editas Medicine, Inc.
Inventors
Aaron WILSON, Christopher Wilson
Abstract
The present disclosure relates to CRISPR-related systems and components for targeting, editing, and/or modulating expression of a CD70 (Cluster of Differentiation 70) gene. The present disclosure also relates to methods and applications thereof in connection with engineered cells including T cells or T cell precursors.
CPC Classifications
A61K 48/005
C12N 5/0636
C12N 9/226
C12N 15/111
C12N 15/85
C12N 2310/20
C12N 2510/00
Filing Date
2025-11-24
Application No.
19398790